RYOSHI will be listed on LBank

2021-07-06


LBank is scheduled to list RYOSHI.

Deposit Open : 12:00, July 7, 2021 (UTC+8)

Trading Open : 12:00, July 8, 2021 (UTC+8)

Withdrawal Open : 12:00, July 9, 2021 (UTC+8)


About RYOSHI

Ryoshi is a meme token that is intended to act as a fan-created utility token, this token appears as Shiba Inu’s father, appropriating his philosophy and solving problems faced by his son, such as high network fees ethereum and high volume tokens, the true Doge Killer solves the infinite coinage problem of dogecoin by implementing a deflationary system to establish itself as the biggest meme currency on the BSC, leveraging its low fees to create the game that will make the Ryoshi token count $1.     


Token information

Symbol:RYOSHI

Type: BEP-20 (BSC)

Website:https://ryoshitoken.com

Whitepaper:https://ryoshitoken.com/wp-content/uploads/2021/07/Ryoshi-Token-Whitepaper.pdf

Explorer:https://bscscan.com/token/0x0e5f989ce525acc4ee45506af91964f7f4c9f2e9


Social Media

Twitter: https://twitter.com/TokenRyoshi

Telegram: https://t.me/ryoshitokenofficial


About LBank

Established in October 2016, LBank is the world class digital asset exchange. LBank provides secure, professional and convenient digital asset exchange services. LBank also has advanced investment services and staking services.


LBank has a team of nearly 300 elite employees with years of experience in the field of blockchain. The top team includes private equity investment experts from traditional financial institutions, tech titans Fortune Global 500 tech companies, and top researchers who have graduated from top tier universities.


LBank is committed to create the most professional digital asset trading platform. To enrich the user experience, LBank launched the ETF trading board. Leverage ETF is a perpetual product without settlement day. Investors can trade leveraged ETF on LBank with the same process of spot trading. There is no margin required, so no liquidation problem. Take purchasing BTC3L (3x long of BTC) as an example, users only need to check the net value, select the proper price, and enter purchase quantity to buy BTC3L.


Follow LBank on Social Media

Website: https://www.lbank.info(www.lbank.me)

Twitter: https://twitter.com/LBank_Exchange

Facebook: https://www.facebook.com/LBank.info/

Reddit: https://www.reddit.com/r/LBankExchange/

Medium: https://medium.com/LBank

LinkedIn: https://www.linkedin.com/company/lbank

CN Telegram: https://t.me/LBank_cn

EN Telegram:  https://t.me/LBank_en



Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map